Compared to Estimates, Adient (ADNT) Q4 Earnings: A Look at Key Metrics

Core Insights - Adient reported $3.69 billion in revenue for the quarter ended September 2025, a year-over-year increase of 3.5% [1] - The EPS for the same period was $0.52, down from $0.68 a year ago, indicating a decline [1] - Revenue exceeded the Zacks Consensus Estimate of $3.63 billion by 1.55%, while EPS fell short of the consensus estimate of $0.55 by 5.45% [1] Revenue Breakdown - Net Sales in the Americas reached $1.79 billion, surpassing the average estimate of $1.76 billion, reflecting a year-over-year increase of 3.9% [4] - Net Sales in Asia amounted to $783 million, exceeding the average estimate of $771.25 million, with a year-over-year change of 2.4% [4] - Net Sales in EMEA were reported at $1.15 billion, above the average estimate of $1.1 billion, showing a year-over-year increase of 3.8% [4] - Net Sales for Eliminations were reported at -$26 million, compared to the average estimate of -$19.94 million, representing a year-over-year change of 4% [4] Stock Performance - Adient's shares have returned -1.2% over the past month, contrasting with the Zacks S&P 500 composite's +1% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]